SCHEMBL648409

SCHEMBL648409

CCCCn1c(-c2ccccc2)nc(-c2ccccc2)c1CN(Cc1ccc(OC(F)F)cc1)Cc1ccc(OC(F)F)c(C)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
C5AR1 P21730 1/20 0.42
TSHR P16473 2/20 0.34
ALDH1A1 P00352 2/20 0.34
HTT P42858 1/20 0.34
KDM4E B2RXH2 1/20 0.33
HPGD P15428 1/20 0.33
HSD17B10 Q99714 1/20 0.33
BACE1 P56817 3/20 0.33
CTSD P07339 1/20 0.33
BACE2 Q9Y5Z0 1/20 0.33
CRHR1 P34998 2/20 0.32
LMNA P02545 1/20 0.32
BCHE P06276 1/20 0.32
DAGLA Q9Y4D2 1/20 0.32
ATP4A P20648 1/20 0.32
ATP4B P51164 1/20 0.32
CASR P41180 1/20 0.32
PDE4B Q07343 1/20 0.32
PPARG P37231 1/20 0.32
PPARA Q07869 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL648891 0.96 C5AR1 (0.44) C5AR1TSHRALDH1A1KDM4EHPGD
SCHEMBL648305 0.95 C5AR1 (0.41) C5AR1TSHRALDH1A1HTTCRHR1
SCHEMBL5134747 0.93 C5AR1 (0.42) C5AR1TSHRALDH1A1KDM4EHPGD
SCHEMBL1915545 0.93 C5AR1 (0.42) C5AR1TSHRALDH1A1KDM4EHPGD
SCHEMBL1913005 0.93 C5AR1 (0.42) C5AR1TSHRALDH1A1HTTKDM4E
SCHEMBL651033 0.92 C5AR1 (0.44) C5AR1TSHRALDH1A1HTTKDM4E
SCHEMBL649513 0.92 C5AR1 (0.43) C5AR1TSHRALDH1A1KDM4EHPGD
SCHEMBL651956 0.91 C5AR1 (0.43) C5AR1TSHRALDH1A1HTTKDM4E
SCHEMBL1912977 0.91 C5AR1 (0.42) C5AR1TSHRALDH1A1HTTCRHR1
SCHEMBL651014 0.91 C5AR1 (0.41) C5AR1TSHRALDH1A1HTTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8119665-B2 Aryl imidazoles and related compounds as C5a receptor modulators NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD. (BM) 2012-02-21 US disclosed
US-8119665-B2 Aryl imidazoles and related compounds as C5a receptor modulators NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD. (BM) 2012-02-21 US disclosed
EP-1490044-A4 COMBINATION THERAPY FOR THE TREATMENT OF CONDITIONS WITH PATHOGENIC INFLAMMATORY COMPONENTS NEUROGEN CORP (US) 2008-04-16 EP disclosed
US-7186734-B2 Aryl imidazoles and related compounds as C5a receptor modulators NEUROGEN CORPORATION (US) 2007-03-06 US disclosed
US-7186734-B2 Aryl imidazoles and related compounds as C5a receptor modulators NEUROGEN CORPORATION (US) 2007-03-06 US disclosed
US-7186734-B2 Aryl imidazoles and related compounds as C5a receptor modulators NEUROGEN CORPORATION (US) 2007-03-06 US disclosed
EP-1490044-A1 COMBINATION THERAPY FOR THE TREATMENT OF CONDITIONS WITH PATHOGENIC INFLAMMATORY COMPONENTS NEUROGEN CORPORATION (US) 2004-12-29 EP disclosed
WO-2003084524-A1 COMBINATION THERAPY FOR THE TREATMENT OF CONDITIONS WITH PATHOGENIC INFLAMMATORY COMPONENTS NEUROGEN CORPORATION (US) 2003-10-16 WO disclosed